Considering this accumulating evidence, it is likely that the PDHK activity and/or the expression of PDHK is pathologically enhanced in the brains of AD and vascular dementia patients where it contributes to reduced PDH activity and metabolic deficits. This evidence concerns the gene PDP1 and vascular dementia.